Awarded contractOpenSuppliesPoland
Sukcesywna dostawa produktu leczniczego zawierającego w swoim składzie substancję czynną niwolumab w ramach realizacji niekomercyjnego badania klinicznego: ,,Efficacy and Tolerability of N-AVD compared to BrECADD in patients with advanced Hodgkin Lymphoma (N-BRAVE)
1 supplier awarded•1 lot awarded•€6.19M awarded
Buyer: Gdański Uniwersytet Medyczny / Gdańsk, Poland
Published Jun 21, 2026Awarded May 27, 2026
Pharmaceutical products
Awarded value
€6.19M
Estimated value
€6.19M
Awarded at 100% of estimated value
Award date
May 27, 2026
Winners
1
Lots awarded
1
Winners
URTICA Sp. z o.o.
1 lotWrocław, POL
€6.2M This contract
499 award notices•1,666 awarded lots•€342.93M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | URTICA Sp. z o.o. | €6.2M | Pharmaceutical products (33600000) |